Drugs / CCS/C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00915187 | Oct → Dec 2009 | influenza | NasVax Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CCS/C | “CCS/C (Adjuvant Formulation)” NCT00915187 ↗ |
| Route | Intramuscular | “given once intramuscularly (IM)” NCT00915187 ↗ |